|
|
|
|
||
In the morning Endpoints email this morning FLXN buyout buzzI got this in the daily Endpoints email today, so a lot of other people did too. https://endpts.com/flexion-nabs-fda-ok-for-its-potential-blockbuster-osteoarthritis-drug-triggering-new-buyout-buzz/ |
return to message board, top of board |